AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the
AngioDynamics Inc.
-(ANGO)
XNAS:ANGO
AngioDynamics (NASDAQ: ANGO) Q2 2020 Earnings Call Transcript
AngioDynamics Inc (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer -- President, Chief Executive Officer, Director Steve Trowbridge -- Senior Vice
AngioDynamics (ANGO): Q2 2020 Earnings Snapshot
-- AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected. -- Net sales remained flat at
AngioDynamics misses Q3 earnings
AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to $86.3 million,
AngioDynamics second-quarter results beat market estimates
AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million, with diluted
Companies reporting earnings this week: Jan 2 – 4
A slew of major companies are reporting earnings this week. Uniform provider UniFirst Corporation (UNF) will announce first-quarter earnings on Thursday before